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A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to
early endosomes is mediated by KIR3DL2
*Simona Sivori,1 *Michela Falco,2 Simona Carlomagno,2 Elisa Romeo,2 Cristiana Soldani,3 Armand Bensussan,4
Antonella Viola,5 Lorenzo Moretta,1,2 and Alessandro Moretta1
1Dipartimento di Medicina Sperimentale (DIMES) and Centro di Eccellenza per la Ricerca Biomedica, Universita` di Genova, Genova, Italy; 2Istituto Giannina
Gaslini, Genova, Italy; 3Laboratory of Adaptive Immunity, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Clinico Humanitas, Milan, Italy;
4Inserm Unit 976 and University Paris 7, Saint-Louis Hospital, Paris, France; and 5Laboratory of Adaptive Immunity, Department of Translational Medicine,
University of Milan, IRCCS Istituto Clinico Humanitas, Milan, Italy
Human natural killer (NK) cells express
Toll-like receptor 9 (TLR9) transcript and,
upon exposure to microbial CpG oligo-
deoxynucleotide (ODN), release cyto-
kines and kill target cells. Here we show
that NK cell treatment with CpG ODN
results in down-modulation of KIR3DL2
inhibitory receptor from the cell surface
and in its cointernalization with CpG ODN.
CpG ODN–induced interferon- (IFN-)
release is mostly confined to KIR3DL2
NK cells, thus suggesting a crucial role of
KIR3DL2 in CpG ODN–mediated NK re-
sponses. Using soluble receptor mol-
ecules, we demonstrate the direct bind-
ing of KIR3DL2 to ODNs and we show that
the D0 domain is involved primarily in
this interaction. KIR3DL2 modulation is
also induced in malignant cells of Se´zary
cutaneous T-cell lymphoma, a disease in
which KIR3DL2 represents a typical
marker of malignant T cells. Confocal
microscopy analysis suggests that, in
human NK cells, CpG ODN can encounter
TLR9 in early endosomes after being
shuttled to these sites by KIR3DL2, which
functions as a CpG ODN receptor at the
cell surface. This novel KIR-associated
function emphasizes the antimicrobial
role of NK cells in the course of infection.
(Blood. 2010;116(10):1637-1647)
Introduction
Innate immunity plays a crucial role in limiting or even in
eradicating pathogens during the early phases of primary infec-
tions, before T and B cells can mount efficient adaptive responses.
Natural killer (NK) cells, phagocytes, and other innate effector
cells do not require clonal expansion to mediate their function and
can enter and defend a tissue almost as soon as it becomes infected.
These effector cells can eliminate pathogens by different mecha-
nisms, including killing of infected cells and secretion of cytokines
and chemokines, which promote inflammation and may further
recruit/activate other cells of the innate immunity. In many
instances, the prompt and different reactions of the innate immu-
nity to pathogen invasion can lead to termination of infection with
no further involvement of the adaptive immunity and no develop-
ment of manifest disease. In addition, thanks to their interaction
with dendritic cells, NK cells may influence the magnitude and the
quality of subsequent adaptive immune responses.1-6 Recent ad-
vances in understanding the biologic role of different cell types of
the innate immunity include mainly the discovery and the molecu-
lar characterization of an array of cell surface receptors. The
structure and the evolution of genes coding for these receptors
reflect mostly the need to adapt to mechanisms of pathogen
evasion. A key example is represented by the human leukocyte
antigen (HLA) class I–specific human killer immunoglobulin
(Ig)–like receptor (KIR)–encoding genes. KIRs belong to the Ig
superfamily and, in most instances, recognize determinants shared
by groups of HLA-A, HLA-B, or HLA-C allotypes.7-11 From an
evolutionary point of view, all KIRs derive from an ancestral
molecule composed of 3 Ig-like domains, D0, D1, and D2
(KIR3D), and a long cytoplasmic tail. The predominant human
KIRs are characterized by 2 Ig-like domains (KIR2Ds).12 There are
2 types of KIR2Ds: the first type (including KIR2DL1/L2/L3 and
KIR2DS1/S2/S3/S4/S5) is composed of domains homologous to
D1 and D2. The majority of these KIRs are specific for HLA-C
molecules. KIRs belonging to the second type contain domains
homologous to D0 and D2 (KIR2DL4/L5). KIRs composed of 3 Ig
domains are specific either for the HLA-Bw4 group of alleles
(KIR3DL1 and possibly KIR3DS1)13 or for some HLA-A alleles
(KIR3DL2).14,15 All KIRs, with the exception of KIR2DL4, display
a clonally distributed expression in human NK cells.7,16,17 KIRs
were also detected on a small subset of cytolytic T lymphocytes18,19
and in the Se´zary cutaneous T-cell lymphoma, in which both
infiltrating and circulating malignant T cells are characterized by
KIR3DL2 expression.20,21
Cells of the innate immune system of vertebrates recognize
pathogen-associated molecular patterns and undergo activation
mainly through specialized molecules called Toll-like receptors
(TLRs). NK cells express different TLRs including TLR2,22
TLR5,23 TLR7,24 TLR3, and TLR9.25 Upon interaction with their
specific ligands (poly I:C and CpG-ODNs, respectively), TLR3 and
TLR9 promote cytokine release and increments of NK cytotoxicity.
Responses to these stimuli were elicited by fresh NK cells as well
as by interleukin-2 (IL2)–cultured NK cell populations.25 Among
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different ODNs, ODN C induced the highest release of cytokines
and increments of cytotoxicity in NK cells.26
Leifer et al27 and Latz et al28 demonstrated that in B cells and
plasmacytoid dendritic cells, respectively, prior to cell stimulation,
TLR9 is localized in the endoplasmic reticulum while, upon cell
exposure to CpG ODN, it translocates to endosomes where both
binding of ODN and initiation of signal transduction take place.
In the present study, we show that exposure of NK cells or
Se´zary T cells to CpG ODNs results in sharp modulation of surface
KIR3DL2 molecules that are rapidly internalized in intracellular
compartments together with CpG ODNs. CpG ODN–induced
interferon- (IFN-) production was confined mostly to NK cells
expressing KIR3DL2. The use of KIR3D or KIR2D soluble
receptors revealed specific binding of ODNs to KIRs bearing the
D0 domain. These data suggest that certain KIRs not only may
function as receptors for HLA class I molecules but also may
mediate the uptake and internalization of CpG ODN, and the
induction of rapid antimicrobial responses.
Methods
Se´zary cell lines and analysis of TLR9 transcript
The Se´zary cell lines used in this study were HUT78, PNO, and CS. Cells
were cultured in RPMI1640 supplemented with 10% fetal calf serum,
10 ng/mL recombinant human IL7 (PeproTech), and 200 UI/mL recombi-
nant human IL2 (Proleukin; Chiron Corp).
Total RNA was extracted from Se´zary cell lines using RNeasy mini kit
(QIAGEN) according to the manufacturer’s instructions, and cDNA
synthesis was performed on 500 ng of RNA using hexameric primers. To
exclude that polymerase chain reaction amplifications were due to DNA
contaminations, RNA was treated with RNase-free DNase (QIAGEN) and
further retrotranscribed in the presence or absence of retrotranscripatse
enzyme (Roche). The primers used for the TLR9 amplification (TLR9 up:
5CAg CCA TAC CAA CAT CCT g and TLR9 down: 5AAA ggA CAC
CCT CTT TTg g) allow for amplification of a segment of 605 bp. The
amplification conditions were 33 cycles: 30 seconds at 95°C, 30 seconds at
55°C, and 30 seconds at 72°C.
Stimulation of human NK cell populations, NK cell clones, and
Se´zary cell lines
Cells were cultured for the indicated time intervals in 24-well plates at a
concentration of 106 in 1 mL of RPMI1640 supplemented with 10% fetal
calf serum, 2 mM L-glutamine, 1% penicillin-streptomycin-neomycin (PSN)
in the absence or presence of different stimuli.
The following modified CpG ODNs were synthesized and purified by
TIB MOLBIOL Srl (Centro di Biotecnologie Avanzate) and used at the
indicated final concentration: ODN 2216 (ODN A) 5-ggG GGA CGA TCG
TCg ggg gg, ODN 2006 (ODN B) 5-tcg tcg ttt tgt cgt ttt gtc gtt, ODN 2395
(ODN C) 5-tcg tcg ttt tcg gcg cgc gcc g, poly A 5-aaa aaa aaa aaa aaa aaa
aaa a, phosphodiester (PO) ODN B 5-TCG TCG TTT TGT CGT TTT GTC
GTT, and PO ODN C 5-TCG TCG TTT TCG GCG CGC GCC G. Bases
shown in capital letters are phosphodiester; those in lower case are
phosphorothioate. ODN C was also synthesized by TIB MOLBIOL Srl with
a 5 fluorescein isothiocyanate (FITC) or Texas red (TxRed) label.
Double-stranded ODN B (ds ODN B) was synthesized by Sigma-Aldrich.
After stimulation, cells were stained with the appropriate monoclonal
antibodies (mAbs), followed by R-phycoerythrin–conjugated, isotype-
specific, goat anti–mouse secondary antibodies (Southern Biotechnology).
Samples were analyzed by 1-color cytofluorimetric analysis (FACScan;
Becton Dickinson).
Results
CpG ODNs induce modulation of surface KIR3DL2 in NK cells
and Se´zary T cells
A panel of NK cell surface markers, including KIRs (Figure 1A),
natural cytotoxicity receptors (NCRs), NKG2D, NKG2A, CD16,
CD56, DNAM-1, CD2, LFA-1, 2B4, NTBA (not shown), was
assessed by cytofluorimetric analysis in IL2-activated NK cell
populations that had been cultured for 20 hours in the presence or
absence of different CpG ODNs. NK cell markers did not reveal
substantial differences in surface expression from unstimulated
controls. A remarkable exception was represented by KIR3DL2.
This KIR was sharply down-regulated, particularly upon cell
treatment with ODN C (Figure 1A). Similar results were obtained
in 10 different donors who were analyzed. Flagellin (TLR5 ligand),
poly U, RNA40 or R848 (TLR7 and TLR8 ligands), and
gardiquimod (TLR7 ligand) did not modify KIR3DL2 expression,
whereas poly I:C (TLR3 ligand) induced some degree of modula-
tion, although this was much less efficient compared with ODN C
(not shown). Moreover, cross-linking of NKp46 or 2B4 using
activating NK receptor–specific mAbs coated to plates did not
modify KIR3DL2 expression (not shown).
As shown by previous studies, KIR3DL2 is also expressed in
the Se´zary cutaneous T-cell lymphoma.20,21 Therefore, we analyzed
whether ODN stimulation could result in down-regulation of
KIR3DL2 on different Se´zary T-cell lines. All 3 analyzed cell lines
(HUT78, PNO, and CS) were KIR3DL2 (Figure 1B), KIR2DL4,
and KIR3DL1/S1 (not shown) and expressed the TLR9-encoding
transcript (Figure 1C). Similarly to NK cells, a sharp modulation of
KIR3DL2 was detected in Se´zary T cells treated with ODN-C
(Figure 1B).
The kinetics of KIR3DL2 modulation was analyzed in NK cell
populations exposed for different time intervals to ODN C. As
shown in Figure 1D, a marked modulation of KIR3DL2 occurred
2 hours after ODN C treatment, although the maximum effect was
reached after 20 hours. Removal of CpG-ODN resulted in re-
expression of KIR3DL2 molecules at the cell surface. Partial
re-expression was detected after 2 to 4 hours, whereas it was fully
restored after 20 hours (Figure 1D).
Uptake of ODN C by KIR3DL2 cells
Because ODN C induced efficient cell surface modulation of
KIR3DL2, we analyzed whether KIR3DL2 was involved in ODN
C uptake. To this end, we first attempted to identify the NK cell
subset capable of capturing FITC–ODN C. Fluorescence-activated
cell sorting (FACS) analysis was performed 2 hours after NK cell
stimulation with ODN C because, at this time point, KIR3DL2 was
still partially detectable at the NK cell surface. Unfractionated NK
cells pretreated with FITC-labeled ODN C were stained with
phycoerythrin-labeled mAbs specific for informative NK cell
markers, including NCRs, KIRs, and NKG2A. Double fluores-
cence analysis revealed that cells capturing FITC–ODN C ex-
pressed KIR3DL2. Because at 2 hours there was a partial down-
modulation of KIR3DL2 (Figure 1D), further experiments were
performed using KIR3DL2 and KIR3DL2 NK cell fractions
purified by FACS sorting. As shown in Figure 2A, KIR3DL2 NK
cells captured ODN C much more efficiently than KIR3DL2 NK
cells. Thus, 35% of KIR3DL2 and only 2% of KIR3DL2 NK
cells were ODN C-FITC. In further experiments, KIR3DL2 and
KIR3DL2 NK cell clones derived from the same donor were
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analyzed. As shown in Figure 2B, the representative KIR3DL2
KIR3DL1/S1 KIR2DL1/S1 KIR2DL2/S2/L3 NKG2A NK
cell clone did capture high amounts of FITC–ODN C, whereas the
KIR3DL2 KIR3DL1/S1 KIR2DL1/S1 KIR2DL2/S2/L3
NKG2A clone did not. Treatment with dextran sulfate, a polyan-
ion known to compete with ODN binding,29,30 strongly inhibited
ODN C uptake by NK cells (Figure 2B).
The role of KIR3DL2 receptor in ODN C uptake was also
evaluated using cell transfectants. Thus, as shown in Figure 2C, the
internalization of ODN C was strongly increased in KIR3DL2-
transfected HEK-293T cells compared with untransfected controls.
Notably, also in this system, a sharp down-modulation of KIR3DL2
could be detected (Figure 2D left).
To analyze whether the cytoplasmic tail of KIR3DL2 could
mediate the receptor internalization upon ODN stimulation, we
transfected HEK-293T cells with a plasmid coding for a truncated
KIR3DL2 molecule lacking the cytoplasmic region (KIR3DL2).
As shown in Figure 2D, the ODN C–induced internalization of
KIR3DL2 was similar to that observed in cell transfectants
expressing the KIR3DL2 full-length receptor. These data suggest
that the KIR3DL2 cytoplasmic tail may not be strictly required for
receptor internalization.
KIR3DL2 NK cells release cytokines in response to ODN C
stimulation
In the presence of IL12, human NK cells were shown to release
abundant cytokines (such as IFN- and tumor necrosis factor-
[TNF-]), in response to stimuli acting on TLRs.25 Thus, NK cell
populations were analyzed for cytokine production in response to
ODN C and IL12. IFN- and TNF- production was assessed by
double fluorescence and FACS analysis in combination with
anti-KIR3DL2 mAb. Because KIR3DL2 was partially modulated
2 hours after stimulation with ODN C, to allow unequivocal
identification of KIR3DL2 NK cells, FACS analysis was per-
formed after 1 hour. As shown in Figure 3A, NK cells releasing
IFN- and TNF- were confined mostly to KIR3DL2 cells. This
result was further confirmed on NK cell clones. Thus, as shown in
Figure 3B, only KIR3DL2 NK cell clones displayed dose-
dependent responses (IFN-) to ODN C stimulation. Notably, both
KIR3DL2 and KIR3DL2 NK cell clones analyzed expressed
high levels of TLR9 transcript and released similar levels of IFN-
in response to PMA plus ionomycin (not shown).
Next, experiments of ODN C uptake were performed in NK
cells pretreated with chloroquine. Because chloroquine blocks the
Figure 1. CpG ODNs induce modulation of surface KIR3DL2 on IL2-activated NK cell populations and Se´zary lymphoma T cells. (A) IL2-activated NK cell
populations were cultured for 20 hours either in the absence or in the presence of ODN A (5 g/mL), ODN B (5 g/mL), or ODN C (5 g/mL) and then assessed by
cytofluorimetric analysis for the surface expression of various NK cell markers. Black profiles indicate the expression of different NK cell molecules. Gray profiles
correspond to isotypic controls. The MFI of the positive peak is indicated in each histogram. Results are representative of 10 distinct experiments. (B) HUT78, PNO, and
CS cell lines were cultured for 20 hours either in the absence (gray profiles) or in the presence (black profiles) of ODN C (5 g/mL) and then analyzed for KIR3DL2 and
CD3 surface expression. Results are representative of 4 distinct experiments. (C) Polymerase chain reaction analysis of TLR9 transcript in HUT 78, CS, and PNO cell
lines. Plus signs () indicate samples obtained by retrotranscription in the presence of RT enzyme, minus signs () samples obtained in the absence of RT enzyme,
used as control for DNA contaminations. Molecular weight marker (MW, given in bp) and no template control (NTC) are also reported. Results are representative of
3 independent experiments. (D) For KIR3DL2-modulation cytofluorimetric analysis of KIR3DL2, expression was assessed on IL2-activated NK cell populations
stimulated with ODN C for different time intervals. For KIR3DL2 re-expression, after 20 hours of stimulation, cells were harvested, washed, and cultured without ODN for
different time intervals. Surface re-expression of KIR3DL2 was analyzed at each time point. Black profiles indicate KIR3DL2 expression, whereas gray profiles
correspond to isotypic controls. The percentage of positive cells and the MFI of the positive peaks are indicated in each histogram. Results are representative of
5 distinct experiments.
A NOVEL KIR-ASSOCIATED FUNCTION 1639BLOOD, 9 SEPTEMBER 2010  VOLUME 116, NUMBER 10
 For personal use only. by guest on December 2, 2011. bloodjournal.hematologylibrary.orgFrom 
acidification process occurring during endosome maturation, it can
prevent ODN-C–mediated triggering of TLR9 localized in endo-
somes.31 Chloroquine treatment did not inhibit ODN C uptake and
only marginally affected KIR3DL2 modulation (Figure 3C), al-
though it strongly inhibited cytokine secretion (dependent on TLR9
signaling; Figure 3D).
Confocal microscopy analysis of KIR3DL2-ODN interactions in
NK cells
To directly visualize the interaction between KIR3DL2 and ODN,
NK cells were incubated either at 4° or 37°C with TxRed-ODN and
stained simultaneously with anti-KIR3DL2 mAbs. mAbs specific
for KIR2DL2/S2/L3 or CD56 were used as control (Figure 4). In
the absence of ODN, the analyzed surface molecules were evenly
distributed on the plasma membrane (Figure 4A). In NK cells
incubated with ODN at 4°C, marked surface clustering of KIR3DL2
occurred, accompanied by a clear colocalization with TxRed-ODN
(Figure 4B). In contrast, KIR2DL2/S2/L3 and CD56 remained
evenly distributed at the cell surface (Figure 4B). In NK cells
incubated with ODN at 37°C for 15 minutes (Figure 4C), KIR3DL2
and ODN were clearly cointernalized and associated inside the
cells (Mander coefficient [M]  0.9 	 0.04). After 30 minutes,
association of KIR3DL2 with ODN was significantly reduced, as
revealed by quantitative colocalization analysis (M  0.56 	 0.07;
P 
 .001), suggesting that, after internalization, the 2 molecules
segregate inside the cell (Figure 4D). Under the same conditions,
no internalization of KIR2DL2/S2/L3 or CD56 was observed
(Figure 4C-D).
To verify whether early endosomes were the site of KIR3DL2/
ODN colocalization, 3-color confocal analysis was performed
using early endosome antigen-1 (EEA-1), a marker of early
endosomes. As shown in Figure 5A, in NK cells incubated at 37°C
for 15 minutes with TxRed-labeled ODN, there was a substantial
overlap between KIR3DL2-ODN and EEA-1 staining. Not surpris-
ingly, colocalization of KIR3DL2-ODN and EEA-1 was signifi-
cantly reduced in NK cells incubated with ODN for 30 minutes
(Figure 5A), suggesting the transfer of ODN to the late endocytic
compartment. This hypothesis was confirmed by quantitative
confocal analysis, using Rab7 as a marker for late endosomes
(Figure 5B). Interestingly, in agreement with data shown in Figure
4, we found that ODN, but not KIR3DL2, colocalized with Rab7 in
NK cells incubated with ODN for 30 or 45 minutes.
A previous, elegant study has demonstrated that a few minutes
after CpG DNA stimulation TLR9 translocates to early endo-
somes.28 On the basis of our data showing the presence of ODN in
early endosomes after 15 minutes of NK cell stimulation (Figure
5A), we hypothesized that from that time on TLR9 would
colocalize with ODN. We addressed this hypothesis by performing
quantitative colocalization analysis of ODN and TLR9 in NK cells
incubated with ODN for 15, 30, or 45 minutes, and found that ODN
and TLR9 were stably associated at all time points (Figure 5C).
Altogether, these data indicate that ODN and KIR3DL2 are
cointernalized in the EEA-1 compartment, where TLR9 translo-
cates upon ODN stimulation.28 In EEA-1 endosomes, KIR3DL2
and ODN dissociate, and ODN and TLR9 travel together toward
Rab-7 late endosomes.
Direct interaction between KIR3DL2 and ODNs
To further investigate whether KIR3DL2 can directly interact with
ODNs, binding experiments were performed using KIR3DL2-Fc
soluble receptors. In addition, because of the KIR3DL2 polymor-
phism (22 alleles have been identified), KIR3DL2*003 and
KIR3DL2*008 (ie, the 2 alleles expressed by the donor shown in
Figure 2) were used. Binding of biotinylated ODN B or ODN C to
plate coated with KIR3DL2-Fc molecules was evaluated.
KIR2DL1-Fc was used as control (KIR2DL1 was not modulated
by ODNs, Figure 1A). As shown in Figure 6A, both
KIR3DL2*003-Fc and KIR3DL2*008-Fc directly bound ODN B
Figure 2. Preferential uptake of ODN C by KIR3DL2 cells. The uptake of
FITC–ODN C by KIR3DL2 or KIR3DL2 NK cell populations sorted from IL2-
activated NK cell populations (A) or KIR3DL2 or KIR3DL2 NK cell clones (B;
derived from the same donor) was analyzed by flow cytometry after 2 hours of
treatment with 5 g/mL FITC–ODN C. In panel A, the percentage of ODN C–FITC
cells is indicated in the right quadrants. In panel B, treatment with dextran sulfate was
used as a negative control (dot profiles). (C) The uptake of FITC–ODN C (full black
profiles) was analyzed on KIR3DL2-transfected HEK-293T cells (right) and
untransfected control (left) after 1 hour of treatment with 1.2 g/mL FITC–ODN C.
Treatment with dextran sulfate was used as a negative control (empty profiles).
Mean fluorescence intensities (MFIs) are reported. (D) HEK-293T cells trans-
fected with plasmid coding for KIR3DL2 full-length receptor (left) or for its
cytoplasmic truncated form (KIR3DL2, right panel) were treated or not for
18 hours with the indicated doses of ODN C, and then KIR3DL2 expression was
assessed by cytofluorimetric analysis. Results shown in each panel are represen-
tative of 3 distinct experiments.
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and ODN C, whereas no ODN/KIR2DL1-Fc interaction was
detected. Addition of dextran sulfate virtually abrogated ODN/
KIR3DL2-Fc interaction, whereas binding of specific anti-
KIR3DL2 mAb to the same coated plates was not affected (Figure
6B). These data are in line with the finding that dextran sulfate
inhibited FITC–ODN C uptake by KIR3DL2 NK cells (Figure
2B). Taken together, these data indicate that KIR3DL2 can directly
bind ODNs and strongly suggest that such interaction may occur at
the NK cell surface as well.
Because confocal microscopy analysis revealed that ODN
dissociates from KIR3DL2 in late endosomal compartments, we
investigated whether the ODN/KIR3DL2 interaction is sensitive to
acid pH. As shown in supplemental Figure 1 (available on the
Blood Web site; see the Supplemental Materials link at the top of
the online article), we could detect a sharp decrease of KIR3DL2
binding capability at pH 5.0. This acid pH, however, had no effect
on KIR3DL2 expression at the NK cell surface as determined by
the use of specific mAb (not shown).
ODN C binding by KIR3DS1, KIR3DL1, and KIR2DL4
We next investigated whether other KIRs could bind ODNs.
KIR-Fc chimeric molecules of KIR3DL1, KIR3DS1, KIR2DL2,
KIR2DL3, KIR2DL4, KIR2DS1, KIR2DS2, and KIR2DS5 (supple-
mental Table 1) were analyzed. Also KIR3DL1-, KIR3DS1-, and
KIR2DL4-Fc were found to bind biotinylated ODN B and ODN C
(Figure 6C). Similar results were obtained using biotinylated ODN
B and ODN C with a full phosphodiester backbone. As shown in
supplemental Figure 2A, KIR3DL2 and KIR3DL1 bound phos-
phodiester (PO) and phosphotioate (PS) ODNs in a dose-dependent
manner, whereas KIR2DL1 and KIR2DL3 did not. On the contrary,
the interaction between KIR2DL4 and CpG ODNs could be
detected with PS ODNs only. These data also suggest that the
affinity of KIR3DL2 and KIR3DL1 is higher for PS ODNs than
for PO ODNs.
We next analyzed whether ODN recognition could be sequence
specific. To this end, we compared the capability of KIR3DL2 and
KIR3DL1 to interact with ODN B, double-stranded (ds) ODN B,
and poly A. As shown in supplemental Figure 2B, all of these short
DNA molecules displayed a dose-dependent binding to KIRs. The
same stimuli were then analyzed for their ability to induce
KIR3DL2 surface modulation. As shown in supplemental Figure 3,
a substantial effect could be observed with all stimuli when used at
high concentration (100 g/mL). Remarkably, only ODN C and ds
ODN B could induce KIR3DL2 down-modulation when used at
low concentration (0.5-5 g/mL).
To investigate whether KIR3DL1, KIR3DS1, and KIR2DL4
also expressed at the cell surface interact with ODNs, we analyzed
HEK-293T cells transfected with plasmids coding for the corre-
sponding KIRs (or for KIR2DL1 or KIR3DL2 as negative and
positive controls, respectively). Each cell transfectant was analyzed
for KIR expression before and after ODN C treatment. As in the
case of KIR3DL2 NK cells, ODN C induced sharp modulation of
Figure 3. KIR3DL2 NK cells release cytokines in response to ODN C stimulation. (A) IL2-activated NK cell populations were cultured for 1 hour in medium supplemented
with 1 ng/mL IL12 either in the absence or in the presence of ODN C (5 g/mL) and then assessed by double fluorescence analysis for IFN- or TNF- production and KIR3DL2
expression. In the upper-right quadrants is indicated the percentage of KIR3DL2 cells that produce cytokines. Results are representative of 5 independent experiments.
(B) IFN- production by KIR3DL2 or KIR3DL2 NK cell clones was assessed by specific enzyme-linked immunosorbent assay after treatment for 2 hours with 1 ng/mL IL12
used alone ( ) or together with 0.5 g/mL ( ), 5 g/mL ( ), or 100 g/mL ( ) ODN C. Results are representative of 3 independent experiments. (C) ODN C uptake by
IL2-activated NK cell populations was analyzed in the absence or presence of chloroquine pretreatment. The upper histograms represent the FITC–ODN C fluorescence
intensity, whereas the lower histograms represent the expression of KIR3DL2 under the same experimental conditions. The percentage of positive cells and the MFI of the
positive peaks are indicated in each histogram. Results are representative of 4 distinct experiments. (D) ODN C–mediated IFN- production by IL2-activated NK cell
populations was analyzed in the absence or presence of pretreatment with chloroquine 0.04 mM (CLQ). IFN- content was assessed by specific enzyme-linked
immunosorbent assay. Data are represented as medians and interquartile ranges (IQRs) of 4 independent experiments.
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KIR3DL2 also in KIR3DL2 HEK-293T transfectants. Under
these experimental conditions, KIR3DL1, KIR3DS1, and KIR2DL4
(but not KIR2DL1) were partially modulated upon cell exposure to
ODN C (supplemental Figure 4A). These data suggest that surface
KIR3DL1, KIR3DS1, and KIR2DL4, although to a lesser extent,
also may be involved in the process of ODN uptake. We further
investigated whether modulation of these KIRs also occurred in
NK cells. Because only some persons express KIR3DL1, KIR3DS1,
and the membrane-bound form of KIR2DL4,33 we analyzed
selected donors expressing all the ODN-binding KIRs. As shown in
supplemental Figure 4B, treatment of IL2-cultured NK cells with
ODN C induced only a partial decrease of surface KIR3DL1/S1
and KIR2DL4 (much less than KIR3DL2). On the other hand, the
surface expression of other members of the KIR family (ie,
KIR2DL1/S1) was not modified (supplemental Figure 4B). Despite
the binding of ODN to KIR3DL1-Fc, the partial ODN C–induced
modulation of surface KIR3DL1 was detected only in some donors
(Figure 1A and supplemental Figure 4B). KIR2DL4 is usually
expressed at very low or undetectable levels by resting NK cells,
whereas its expression is transiently up-regulated in IL2-cultured
NK cells.34 Because NK cell populations analyzed in these
experiments expressed low levels of KIR2DL4, only slight ODN
C–induced modulation could be detected (supplemental Figure
4B). Similar to IL2-activated NK cells, ODN C treatment of freshly
isolated peripheral blood NK cells induced strong KIR3DL2 but
only partial KIR3DL1 modulation (Figure 6D).
Role of the D0 domain in KIR/ODN interaction
The analysis of the domain compositions of different KIRs
suggested that the capability of a given KIR to bind ODN might
correlate with the presence of the D0 domain. To assess whether the
D0 domain is involved in CpG-ODN recognition, Fc chimeric
soluble proteins composed of 1 or 2 domains were generated. In
particular, we assessed the binding capability of single D0-Fc
domains of KIR3DL1, KIR3DL2, KIR3DS1, and KIR2DL4; D1
D2 of KIR3DL1, KIR3DL2, and KIR3DS1; single D1 of KIR3DL1
and KIR3DS1; and single D2 of KIR3DL1 and KIR3DS1 (supple-
mental Table 2). The results, summarized in Figure 7, strongly
suggest a direct involvement of D0 domains in ODN binding.
Moreover, KIR3DL1 and KIR3DS1 (alleles of the same locus)
bound ODNs also through the D1  D2 domains. Thus, the ability
of single D1 or D2 of KIR3DL1 and KIR3DS1 to bind ODNs was
also examined. As shown in Figure 7, the single D1 or D2 domains
of both KIR3DL1 and KIR3DS1 receptors displayed only weak
binding to ODNs (more evident at higher ODN concentration).
Figure 4. Visualization of KIR3DL2-ODN interaction in NK
cells. Confocal microscopy analysis of NK cells untreated (A) or
incubated with 5 g of TxRed-ODN (red) for 30 minutes at
4°C (B), or for 15 or 30 minutes at 37°C (C-D). Cells were then
stained for KIR3DL2, KIR2DL2/S2/L3, or CD56 (green), as indi-
cated. Images are single confocal sections taken with a 60
objective. Scale bar represents 2 m. Quantitative colocalization
analysis was performed to compare panels C and D, and it
provided the following Mander coefficients of colocalization:
0.9 	 0.04 (C), 0.56 	 0.07 (D); P 
 .001.
1642 SIVORI et al BLOOD, 9 SEPTEMBER 2010  VOLUME 116, NUMBER 10
 For personal use only. by guest on December 2, 2011. bloodjournal.hematologylibrary.orgFrom 
This suggests that an appropriate spatial conformation, determined
by D1  D2 domains of KIR3DL1/S1, is required for binding
ODN. On the contrary, D1  D2-Fc of KIR3DL2 did not bind
ODNs, indicating that, in KIR3DL2, the D0 domain is the only one
responsible for the interaction with ODNs. Next, we comparatively
analyzed the net charges of the ODN-binding KIRs with those of
the nonbinding ones. This analysis, reported in supplemental Table
3, revealed that the extracellular portions of KIR3DL1, KIR3DL2,
KIR3DS1, and KIR2DL4 display a positive charge, whereas those
of KIR2DL1 and KIR2DS2 do not. Moreover, we found that the
KIR domains showing the higher positive net charge were the ones
that displayed the higher ODN-binding capability.
Discussion
KIRs were originally discovered and characterized as surface NK
receptors specialized in HLA class I recognition.8-10 The present
study provides evidence for a novel, relevant functional capability
of these molecules, suggesting that they may function as sensors
for microbial products. Primarily KIR3DL2, an inhibitory NK
receptor specific for certain HLA-A alleles,14,15 can bind CpG
ODNs at the cell surface and shuttle them to endosomes where
TLR9s are localized. Interaction of KIR3DL2 with ODN resulted
in sharp down-modulation of its surface expression and in induc-
tion of cytokine release. Remarkably, binding of ODN to KIR3DL2
did not result in the delivery of inhibitory signals, as it occurs when
KIR3DL2 is engaged by its HLA-A–specific ligands. This may
reflect simply the lack of appropriate KIR cross-linking. In this
context, also KIR-specific mAbs do not deliver inhibitory signals in
the absence of efficient cross-linking. It is also possible that the
transient disappearance of KIR3DL2 from the cell surface (upon
ODN uptake) may allow NK cells to kill target cells expressing
“protective” HLA-A molecules.
It has been shown that KIR3DL2 represents a valuable marker
for Se´zary cutaneous T-cell lymphoma. Both cutaneous and
circulating cells of this lymphoma express KIR3DL2.20,21 In
agreement with a previous report,35 we show that Se´zary cells
express TLR9 transcripts. After exposure to ODN, a sharp down-
regulation of KIR3DL2 occurred in T-cell lines established from
different Se´zary patients. However, in this case, we could not
evaluate functional responses to ODN because Se´zary cells do not
secrete detectable levels of cytokines (despite TLR9 transcript
expression). Notably, KIR3DL2, differently from other KIRs, has
not been detected in T cells from most healthy persons. A role in the
pathogenesis of Se´zary T-cell lymphoma has been proposed for
skin-associated microbes such as Staphylococcus aureus36 and
Chlamydia.37 Other studies reported an association between this
lymphoma and cytomegalovirus38 or Epstein-Barr virus infec-
tions.39 In this context, microbial ODN-mediated cell triggering
may induce uncontrolled proliferation of KIR3DL2 Se´zary T cells,
possibly representing an early event in the tumorigenic process
leading to the malignant lymphoma.
One of the problems in TLR biology is represented by the
delivery of ligands to endosomal/endoplasmic reticulum–resident
TLRs. ODN binding, internalization, and traffic were analyzed by
confocal microscopy. Notably, in these experiments, we used
normal NK cells (and not cell lines or cell transfectants) to ensure a
more physiologic experimental setting. KIR3DL2 molecules were
found to be associated with ODN not only at the cell surface but
also intracellularly. Our data indicate that KIR3DL2 and ODN are
cointernalized through early (EEA-1) endosomes, but then they
separate and ODN proceeds in trafficking only through the late
(Rab7) compartment. Interestingly, we have found that, in con-
trast to KIR3DL2, TLR9 is stably associated with ODN during its
residency in both early and late endosomes. Thus, although it
cannot be excluded that a vanishing small amount of TLR9 may be
expressed on the NK cell surface, our data suggest that, at least in
NK cells, surface molecules such as KIR3DL2 may function as
chaperons for TLR9 ligands. At the present, however, we cannot
rule out the possibility that an additional yet-undefined molecule
may be necessary for the process of KIR3DL2-mediated ODN
internalization, as suggested by the experiments with KIR3DL2.
Importantly, the use of KIR3DL2-Fc soluble molecules allowed us
to directly assess their binding to ODN. These experiments
suggested that binding of ODN does not require additional
molecules associated with KIR3DL2 at the NK (or T) cell surface.
KIR-Fc specific for HLA-C alleles (KIR2DL1/S1 and KIR2DL2/
L3/S2) did not bind ODN, whereas substantial binding was
detected with other KIR-Fc soluble proteins including KIR3DL1,
KIR3DS1, and KIR2DL4. Remarkably, all the ODN-binding KIRs
are characterized by a D0 domain. Analysis of the ODN-binding
Figure 5. ODN traffics through early and late endosomes and associates with
TLR9. Confocal microscopy analysis of NK cells incubated with 5 g of TxRed-ODN
(red) for 15, 30, or 45 minutes at 37°C. Cells were then stained for (A) EEA-1 (green)
and KIR3DL2 (purple), (B) KIR3DL2 (green) and Rab7 (purple), or (C) TLR9 (green),
as indicated. Images are single confocal sections, taken with a 60 objective,
showing NK cells incubated with ODN for 15 minutes (A,C) or 30 minutes (B). Scale
bar represents 2 m. Quantitative colocalization analysis expressed as Mander
coefficients of colocalization is shown. ***P 
 .001 was considered significant.
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capability of individual Ig domains revealed a predominant involve-
ment of D0. Previous studies showed that KIR3DL1 recognizes
HLA class I through D1 and D2 domains, whereas the D0 domain
enhances the strength of KIR/HLA interaction.40 Our studies
provide evidence for a novel major function of D0 (ie, to mediate
direct pathogen recognition). Unfortunately, because none of the
available anti-KIR3DL2 mAbs react with this domain, the binding
of ODN could not be prevented by these antibodies. Although
soluble KIR3DL1, KIR3DS1, and KIR2DL4 could bind ODNs,
these did not induce, in normal NK cells, modulation of the
corresponding membrane receptors comparable with that of
KIR3DL2. Differences in KIR susceptibility to ODN-induced
modulation could not be explained merely by differences in surface
density. For example, modulation of KIR3DS1 was marginal,
although its level of expression at the NK cell surface was similar
to or weaker than that of KIR3DL2. Remarkably, IFN- production
in response to ODN was confined mostly to KIR3DL2 NK cell
subsets, suggesting that other ODN-binding KIRs do not mediate
efficient ODN-shuttling into NK cells.
The putative ancestral mammalian KIR was a 3-domain surface
molecule carrying a D0 domain. All KIR2D-encoding genes are
thought to have evolved from a KIR3D-encoding gene. Indeed, the
majority of KIR2D genes contain a pseudoexon encoding a D0
domain.12,41 Among KIR2D, only KIR2DL4 and KIR2DL542 (this
latter was not analyzed in the present study) carry D0 domain. They
represent the most conserved KIRs in primates, being the only ones
Figure 6. ODNs directly bind KIR3DL2-Fc and down-regulate the expression of KIR3DL2 in freshly isolated NK cells. (A) Plates coated with KIR3DL2*003-,
KIR3DL2*008-, or KIR2DL1-Fc soluble receptors were incubated with biotinylated sequence of ODN B or ODN C followed by streptavidin horseradish peroxidase
(HRP)–conjugated second reagent or with anti–human IgG HRP-conjugated mAb. Arbitrary units (AU) on y-axis represent the ratio between optical density (OD) values
obtained by analyzing ODN/KIR-Fc interaction and OD values obtained by testing binding of anti–human IgG HRP to the corresponding KIR-Fc molecules. Results are
presented as medians of 3 to 8 independent experiments, each performed in duplicate. IQRs are reported. (B) Binding of ODN C to plates coated with KIR3DL2*003-Fc was
tested in the absence or presence of dextran sulfate (DS) at the indicated concentrations. As control, we measured binding of an anti-KIR3DL2 mAb to KIR3DL2*003-Fc under
the same experimental condition. AUs on y-axis represent the ratio between OD values obtained analyzing ODN/KIR3DL2-Fc interaction or mAb/KIR3DL2-Fc interaction and
OD values obtained by testing the binding of anti–human IgG HRP to KIR3DL2-Fc–coated plates. A representative experiment of 3 independent ones is reported. (C) Binding of
biotinylated sequences of ODN B or ODN C to plates coated with the indicated KIR-Fc molecules was determined and represented as described in panel A. Bars represent
medians of 3 to 8 independent experiments performed in duplicate; IQRs are reported. (D) Freshly isolated NK cells were cultured for 20 hours either in the absence or in the
presence of ODN C, and then assessed by double cytofluorimetric analysis for CD56 and KIR3DL2 (Q66 mAb) or KIR3DL1 (Z27 mAb) or KIR3DL2 and KIR3DL1 (AZ158 mAb)
expression. AZ158dull and AZ158bright NK cells correspond to KIR3DL2 and KIR3DL1 NK cells, respectively.32 Mean fluorescence intensities (MFIs) are reported. Results are
representative of 3 independent experiments.
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common to hominoids (KIR2DL4 and KIR2DL5) and monkeys
(KIR2DL4).43 This might suggest that, in origin, these receptors
had a function different from their ability to recognize major
histocompatibility complex class I allele. In this context, it is worth
noting that KIR3DL2 (together with KIR2DL4 and KIR3DL3)
represents a framework gene (ie, it is present in all KIR haplo-
types).41 As a consequence, NK cells of all persons can bind CpG
ODN. This novel functional capability of KIR3DL2 may provide
an important clue to understanding the driving forces that led to
conservation of the KIR3DL2-encoding gene in all haplotypes,
despite the low frequency, in the human population, of HLA-A3 or
-A11 alleles (ie, the ligands of KIR3DL2). Indeed, the need of rapid
NK-mediated responses to microbial products may represent an
important factor of selective pressure. In this context, KIR3DL2 is
characterized by a low inhibitory capability because of its low
affinity for its HLA-A ligand. Moreover, such interaction is highly
dependent on the peptide bound to the HLA pocket.44 This impaired
inhibitory function may explain why KIR3DL2, in most NK cells,
is coexpressed with other KIRs or NKG2A, which ensure a more
efficient inhibitory effect upon interaction with their HLA class
I–specific ligands. Thus, it is possible to speculate that the
prevalent role of KIR3DL2 in humans may be its ability to
promptly sense microbial CpG ODNs.
KIR3DL2 is expressed by NK cells and by Se´zary T cells.
However, because KIR3DL2-negative cell types (other than NK
cells) are known respond to ODN, it is likely that other surface
Figure 7. The D0 domains of KIR3DL2, KIR3DL1, KIR3DS1, and KIR2DL4 are involved in ODN recognition. (A) Each graph represents the ODN-binding capability of the
full-length ectodomain of the reported KIRs and of their indicated extracellular domains. The starting and ending amino acids composing the indicated domains are listed in
supplemental Table 2. Experimental conditions and data representations are described in Figure 6A. Results are reported as medians of 3 to 8 independent experiments, each
performed in duplicate. IQRs are indicated. (B) KIR molecules and their domains were analyzed as titrations for the capability to bind ODN C. Experiments were performed and
elaborated as described in Figure 6A. Data are represented as medians and IQRs of 4 independent experiments.
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receptors may ensure ODN uptake and delivery to TLR-containing
endosomes.45,46 For example, a 45-kDa protein expressed in kidney
brush border membranes has been reported to act as a voltage-gated
channel for the entry of ODN into these cells. However, no
evidence exists that this protein is expressed in leukocytes as
well.47 In macrophages, type I and II class A scavenger receptors
(scavenger receptor AI/II, SR-A) and macrophage receptor with
collagenous structure (MARCO) have been reported to bind CpG
ODNs. However, SR-A– or MARCO-deficient macrophages could
respond to ODN, suggesting a redundant function of these recep-
tors in ODN uptake at least in macrophages.48-50 Although not
shown, transcripts coding for SR-A and/or MARCO were not
detected in IL2-activated NK cells.
Although KIR2DL4 was only partially down-regulated in NK
cells exposed to CpG ODN, we speculate that it could also play a
role in the uptake of microbial products. Differently from all the
other KIRs, KIR2DL4 is present in all NK cells. Thus, in view of its
broad expression profile and its evolutionary conservation,
KIR2DL4 is likely to play a critical role in NK cell biology. It has
been reported that HLA-G and some HLA class I alleles are ligands
for membrane-bound KIR2DL4. In this regard, Rajagopalan et al
showed that KIR2DL4 surface molecules, upon interaction with
soluble HLA-G, undergo endocytosis and colocalize with Rab5, a
marker of early endosomes where also TLR9s are located.16
In conclusion, our present study provides evidence of a novel,
KIR-associated function. Notably, thanks to their ability to recog-
nize HLA class I molecules, KIRs were known to play a fundamen-
tal role in viral infections, allowing discrimination between virus-
infected and normal cells. This study underlines the important role
of KIRs as sensors of CpG ODN. This would result in rapid NK
responses, primarily characterized by cytokine production, also in
the course of bacterial infections.
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